1. Indian Council of Medical Research, National Centre for Disease Informatics and Research. GLOBOCAN India 2020: Report on cancer incidence and mortality [Internet]. ICMR-NCDIR; 2020.
2.
Datta NR, Kumar S, Singh S et al. Brachytherapy in the treatment of cervical cancer: Current status and emerging trends. Gynecol Oncol 2015; 138: 412-419.
3.
Pötter R, Tanderup K, Kirisits C et al. The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies in image guided adaptive brachytherapy for cervical cancer. Clin Transl Radiat Oncol 2018; 9: 48-60.
4.
Viswanathan AN, Thomadsen B. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: High-dose-rate brachytherapy. Brachytherapy 2012; 11: 47-52.
5.
Chargari C, Deutsch E, Blanchard P et al. Physics aspects of modern cervical cancer brachytherapy. Cancer Radiother 2014; 18: 236-239.
6.
Nomden CN, de Leeuw AA, Moerland MA et al. Clinical use of the Utrecht interstitial CT/MR applicator in cervical cancer brachytherapy: Dose-volume parameters in relation to clinical outcome. Radiother Oncol 2012; 103: 173-180.
7.
Mahantshetty U, Krishnatry R, Hande V et al. Magnetic resonance image guided adaptive brachytherapy in locally advanced cervical vancer: An experience from a tertiary cancer center in a low and middle income countries setting. Int J Radiat Oncol Biol Phys 2017; 99: 608-617.
8.
Pötter R, Haie-Meder C, Van Limbergen E et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy – 3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2005; 78: 67-77.
9.
Rooney MK, Rosenberg DM, Braunstein S et al. Three-dimensional printing in radiation oncology: A systematic review of the literature. J Appl Clin Med Phys 2020; 21: 15-26.
10.
Yoshida K, Yamazaki H, Kotsuma T et al. Simulation analysis of optimized brachytherapy for uterine cervical cancer: Can we select the best brachytherapy modality depending on tumor size? Brachytherapy 2016; 15: 57-64.
11.
Dimopoulos JCA, Lang S, Kirisits C, Pötter R. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results. Int J Radiat Oncol Biol Phys 2006; 66: 83-90.
12.
Pötter R, Tanderup K, Kirisits C et al., EMBRACE Collaborative Group. The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol 2018; 9: 48-60.
13.
Beriwal S, Demanes DJ, Erickson B et al. American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer. Brachytherapy 2012; 11: 68-75.
14.
Fokdal L, Tanderup K, Nielsen SK et al. Clinical feasibility of combined intracavitary/interstitial brachytherapy in locally advanced cervical cancer using the Vienna applicator. Int J Radiat Oncol Biol Phys 2013; 85: 641-646.
15.
Kirisits C, Pötter R, Lang S et al. Dose-volume histogram parameters and local control in magnetic resonance image-guided cervical cancer brachytherapy. Int J Radiat Oncol Biol Phys 2006; 66: 508-516.
16.
Hong DQ, Li Z, Wang L et al. Dosimetric benefit of IC/IS+ISBT-DP based on parametrial extension width in image-guided brachytherapy for locally advanced cervical cancer. Brachytherapy 2020; 19: 211-219.
17.
Wark A, Hüfner L, Meixner E et al. Clinical impact of MRI-guided intracavitary–interstitial brachytherapy in the curative management of advanced stage cervical cancer. Curr Oncol 2025; 32: 136.
18.
Haider J, Faheem M, Nazemniya F et al. Acute toxicity profile and treatment response of image guided hybrid brachytherapy using Venezia applicators in locally advanced cervical cancer: a single centre experience in Pakistan. Ecancermedicalscience 2025; 19: 1883.
19.
Le NA, Patel S, Mutyala K et al. Outpatient hybrid intracavitary-interstitial brachytherapy for cervical cancer with minimal sedation in a freestanding setting. Pract Radiat Oncol 2025; 59: 101767.
20.
Rivera A, Wassel M, Brodin PN et al. Hybrid tandem and ovoids brachytherapy in locally advanced cervical cancer: impact of dose and tumor volume metrics on outcomes. J Contemp Brachytherapy 2021; 13: 158-166.
21.
Najjari-Jamal D, Juarez M, Cordoba S et al. The crucial role of advanced image-guided brachytherapy for locally advanced cervical cancer in the era of systemic treatment intensification. Cancers (Basel) 2025; 17: 1809.
22.
Chino J, Beriwal S, Albuquerque K et al. The American Brachytherapy Society (ABS) consensus guidance for hybrid intracavitary interstitial brachytherapy for locally advanced cervical cancer. Brachytherapy 2025; 24: 463-478.
